Preoperative Prophylactic Fosfomycin Trometamol Versus 5-day Levofloxacin in Prevention of Postpercutaneous Nephrolithotomy Infectious Complications and Sepsis.
Comparison of Preoperative Prophylactic Single Dose Fosfomycin Trometamol Versus 5-day Levofloxacin in Prevention of Post-percutaneous Nephrolithotomy Infectious Complications and Sepsis: A Prospective Randomized Controlled Trial.
1 other identifier
interventional
210
1 country
1
Brief Summary
A randomized controlled trial comparing the use of preoperative prophylactic single dose fosfomycin trometamol versus levofloxacin in prevention of post-PCNL infectious complications and sepsis. the 3 groups were compared as regards the baseline data, preoperative data, intra-operative data, and post-op data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 2, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
January 12, 2026
CompletedFirst Posted
Study publicly available on registry
January 21, 2026
CompletedJanuary 21, 2026
January 1, 2026
1.5 years
January 12, 2026
January 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
post-operative infectious complications and sepsis
1 week
Study Arms (3)
Preoperative Fosfomycin Trometamol group
ACTIVE COMPARATORFosfomycin before PCNL
Preoperative 5-day Levofloxacin group
ACTIVE COMPARATORLevofloxacin before PCNL
No preopertive antibiotic group
OTHERcontrol, no preoperative antibiotic before PCNL
Interventions
PCNL for renal stones
Eligibility Criteria
You may qualify if:
- adult patients with renal stones scheduled for PCNL
You may not qualify if:
- Unfit patients for surgery
- patients with active UT
- uncorrected coagulopathy
- pregnancy
- children
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
Faculty of medicine, Tanta University
Tanta, 11511, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Tanta, ElGeish street, Gharbiya government, Egypt
Study Record Dates
First Submitted
January 12, 2026
First Posted
January 21, 2026
Study Start
January 1, 2023
Primary Completion
July 2, 2024
Study Completion
January 1, 2025
Last Updated
January 21, 2026
Record last verified: 2026-01